The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
oxaliplatin
An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane (DACH) and with an oxalate ligand as a 'leaving group.' A 'leaving group' is an atom or a group of atoms that is displaced as a stable species taking with it the bonding electrons. After displacement of the labile oxalate ligand leaving group, active oxaliplatin derivatives, such as monoaquo and diaquo DACH platinum, alkylate macromolecules, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity. The DACH side chain appears to inhibit alkylating-agent resistance. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | diaminocyclohexane oxalatoplatinum oxalatoplatin oxalatoplatinum | |
| |||
| US brand name: | | Eloxatin | |
| |||
| Foreign brand names: | | Dacotin Dacplat Eloxatine | |
| |||
| Abbreviations: | | 1-OHP L-OHP | |
| |||
| Code names: | | JM-83 RP-54780 SR-96669 | |
| |||
| Chemical structures: | | [(1R,-2R)-1,2-cyclohexanediamine-N,N'][oxalato (2--)-O,O']platinum [SP-4-2-(1R-trans)]-(1,2,cyclohexanediamine-N,N')[ethanedioato(2--)-O,O']platinum oxalato (1R,2R-cyclohexanediamine)platinum(II) oxalato (trans-l-1,2-diaminocyclohexane)platinum(II) trans-l DACH oxalatoplatinum trans-l diaminocyclohexane oxalatoplatinum | |
| |||
